Longitudinal changes in bone mineral density after initiation of elexacaftor-tezacaftor-ivacaftor in youth and adults with cystic fibrosis: PROMISE-ENDO

Meghan K. Shirley(Children's Hospital of Philadelphia), Maria Ycaza, R. Perkins, Jenna Bucher, Iman Sami, Lucas R. Hoffman(University of Washington), Katie Larson Ode(University of Iowa), Clement L. Ren, Jo Billings, Maria Mcleod, Steven D. Freedman(Beth Israel Deaconess Medical Center), Alvin Singh, Donna Lach, Danielle Wolfe, Joy Dangerfield, C. Frederick(Jacobs Institute), Raksha Jain(Westmead Institute for Medical Research), Margot Hardcastle, Jane B. Vroom, Jean Malpass, Scott D. Sagel(SUNY Upstate Medical University), Karen Z. Voter, Daniel Gelfond, Larissa Rugg, Elliott C. Dasenbrook(Cleveland Clinic), Susanna A. McColley(Northwestern University), Kelvin D. MacDonald, Erin Donnelly, Kevin Kirchner, R. Gallop(University of Pennsylvania), Barbara Johnson(Johnson & Johnson (United States)), Holly Carveth, Michael R. Narkewicz(Children's Hospital Colorado), M. Teresi, James Melson, Scott H. Donaldson(University of North Carolina at Chapel Hill), David Weaver, George M. Solomon(University of Alabama at Birmingham), Christine L. Chan(Children's Hospital Colorado), Rachel Walega(Children's Hospital of Philadelphia), Christopher Richards, Heather Thomas, Claire Keating(Pulmonary and Allergy Associates), Babette S. Zemel(Children's Hospital of Philadelphia), Erin Canning, Andrea Kelly(Children's Hospital of Philadelphia), Mary Bailey, Steven M. Rowe(Cystic Fibrosis Foundation), Olivia Killilea, Sarah Jane Schwarzenberg(University of Minnesota Children's Hospital)
Journal of Cystic Fibrosis
January 30, 2026
Cited by 0


Related Papers